Guideline for clinical management of exposure to lead

Zusammenfassung

WHO GUIDELINE FOR THE CLINICAL MANAGEMENT OF EXPOSURE TO LEAD | 1 WHO guideline for the clinical management of exposure to lead ISBN 978-92-4-003704-5 (electronic version) ISBN 978-92-4-003705-2 (print version) © World Health Organization 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may c

Kerninformationen

rs. To submit requests for commercial use and queries on rights and licensing, see https://www.who.int/about/policies/publishing/copyright. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your respons...

Abbreviations and acronyms Executive summary The Guideline 01 / Purpose and scope 02 / Methods for guideline development 2.1 Contributors to the guideline 2.2 Identification of priority questions and critical outcomes 2.3 Identification and retrieval of evidence 2.4 Quality assessment and grad...

.3 Chelation therapy 10 / Considerations for implementation of the guideline References Annex 1 Members of the WHO Steering Group Annex 2 Guideline Development Group Annex 3 Research questions and critical and important outcomes Annex 4 External reviewers Annex 5 Flowcharts summarizing aspec...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen